We are thrilled to announce that our CEO, Sandip Patel, will be pitching at the TiE New Jersey Nurture Cohort 3 Demo Day on June 5th. Sandip Patel will discuss our unique competitive business strategy, unmet medical need, and our groundbreaking patent-pending solution. This is a fantastic opportunity to learn more about how we are driving innovation in healthcare.
Whether you're an investor, potential partner, or enthusiast, we'd love to engage and explore potential collaborations. Reach out to us at investors@biovericpharma.com.
Let's drive healthcare innovation — together!
BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.